Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 979 of 5804
-
Spinal zaps may quiet overactive muscles in kids with cerebral palsy
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether dorsal root electrical stimulation could reduce spasticity in children with cerebral palsy (CP).
Phase: NA • Sponsor: Martin Piazza • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New pill aims to ease psoriatic arthritis pain
Disease control Recruiting nowThis study is a marketing-oriented clinical trial of TQH3906 Capsules. A total of 156 participants are planned to be enrolled, aiming to evaluate the dose-effect relationship of TQH3906 versus placebo in the treatment of active Psoriatic Arthritis (PsA) at Week 12, with the propo…
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New 'In-Body' CAR-T therapy takes aim at Hard-to-Treat lymphoma
Disease control Recruiting nowKSVCBD injection is an in vivo Chimeric Antigen Receptor T-Cell (CAR-T cell) therapy product. This multicenter, single-arm, open-label, early exploratory clinical study is designed to evaluate the preliminary safety and efficacy of KSVCBD injection in patients with relapsed or re…
Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Blue light therapy could drain abscesses faster
Disease control Not yet recruitingThe objective of this Phase 2 study is to evaluate the efficacy of methylene blue photodynamic therapy (MB-PDT) performed at the time of percutaneous abscess drainage for disinfection of deep tissue abscesses. The study includes three arms: (1) MB-PDT at a fixed drug/light dose p…
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Mind over menopause: brain training trial targets hot flashes and mood
Symptom relief Recruiting nowThe goal of this study is to evaluate a neuroplasticity-based mind-body intervention, Amygdala and Insula Retraining (AIR), compared to a wait-list control in individuals experiencing perimenopausal symptoms. Our research questions include: Does AIR reduce overall perimenopausa…
Phase: NA • Sponsor: Chronic Conditions Research Fund • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New implant could help opioid users stay clean for months
Disease control Not yet recruitingThis study will examine the safety and efficacy of the O'Neil Long Acting Naltrexone Implant (OLANI) in persons with opioid dependency who are seeking relapse-prevention treatment. All participants will be treated in an open label manner. No randomization will occur. The OLANI is…
Phase: PHASE2 • Sponsor: Go Medical Industries Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New cream aims to soothe butterfly skin in Late-Stage trial
Symptom relief Not yet recruitingThe objective is to characterize the continued safety of SD-101 cream containing 6% allantoin in the treatment of the skin in patients with Simplex, Recessive Dystrophic, or JEB-nH EB.
Phase: PHASE3 • Sponsor: Paradigm Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Could a light cap save infant brains after cardiac arrest?
Disease control Not yet recruitingApproximately 15,200 children receive cardiopulmonary resuscitation (CPR) for in-hospital cardiac arrest (IHCA) each year in the United States. Of these, about 60% are less than one year of age. Most IHCA (85-90%) occurs in intensive care units (ICU) or other monitored settings. …
Phase: NA • Sponsor: Mitovation, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New heart surgery combo could spare patients from open chest incision
Disease control Not yet recruitingCoronary artery disease often necessitates complex interventions like coronary artery bypass surgery (CABG) or percutaneous coronary intervention (PCI) with stents. Hybrid coronary revascularization, a minimally invasive approach, integrates both methods for complete revasculariz…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for lung cancer patients: drug combo targets tough tumors
Disease control Not yet recruitingThis prospective, single-arm, exploratory multicenter clinical study aims to investigate the safety and efficacy of Becotatug vedotin combined with Pucotenlimab (with or without radiotherapy), followed by Pucotenlimab maintenance therapy, in patients with driver gene-negative (e.…
Phase: PHASE2 • Sponsor: Anhui Provincial Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Cottonseed compound plus immunotherapy takes on tough colorectal cancer
Disease control Not yet recruitingThis is a single-center, open-label, single-arm, exploratory phase II clinical trial designed to evaluate the preliminary efficacy and safety of sintilimab in combination with oral gossypol acetate in patients with advanced pMMR/MSS colorectal cancer after failure of at least two…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New program aims to give veterans with advanced cancer a stronger voice in their End-of-Life care
Symptom relief Not yet recruitingIn 2017, the VA launched the Life-Sustaining Treatment Decisions Initiative (LSTDI), a national program to promote Goals of Care communication between clinicians and patients regarding goals and preferences for care. Despite clinician training and standardized Life Sustaining Tre…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Rhythmic sound may retrain the brain to walk better after TBI
Symptom relief Not yet recruitingThe goal of this study is to learn whether a home-based rhythmic auditory stimulation (RAS) program using the MR-001 device can help improve walking, balance, and other health outcomes in adults with moderate to severe traumatic brain injury (TBI). The study will also look at how…
Phase: NA • Sponsor: Craig Hospital • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Real-World study tests Once-Daily pill for ulcerative colitis in chinese adults
Disease control Not yet recruitingUlcerative colitis (UC) is a chronic inflammatory bowel disease that causes symptoms such as bloody diarrhea, abdominal pain, and frequent bowel movements. It can significantly affect patients' quality of life. Etrasimod is an oral medication taken once daily that has been shown …
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New nerve block could replace morphine for C-Section pain
Symptom relief Not yet recruitingEffective postoperative analgesia after cesarean delivery is essential for maternal recovery, early mobilization, breastfeeding, and maternal-infant bonding. Although intrathecal morphine (ITM) is considered the gold standard for post-cesarean analgesia, its use is associated wit…
Phase: NA • Sponsor: Ondokuz Mayıs University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Virtual reality nature escape may calm fear of childbirth in High-Risk pregnancies
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effect of a virtual reality (VR) video intervention on fear of childbirth and anxiety among hospitalized high-risk pregnant women receiving bed rest. High-risk pregnancy and prolonged hospitalization may increase psychological…
Phase: NA • Sponsor: Sümeyye BAL • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New Vaccine-Chemo combo shows promise for Tough-to-Treat tumors
Disease control Recruiting nowThis phase IIa trial compares the safety and effect of temozolomide combined with survivin long peptide vaccine (SurVaxM) to temozolomide alone in patients with neuroendocrine tumors (NET) that has spread from where it first started (primary site) to other places in the body (met…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Marathon runners and heart patients put a new troponin test to the ultimate challenge
Diagnosis Recruiting nowTroponin elevation can, among others, be due to myocardial infarction, acute inflammation or structural heart disease. Formation of macrocomplexes against troponin is an underestimated cause for persistent troponin elevation. Polyethlylene glycol precipitation (PEG) can different…
Phase: NA • Sponsor: Technical University of Munich • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
Mayo clinic tests urine and blood for kidney cancer clues
Diagnosis Not yet recruitingThis is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molecular tests for patients with renal cell carcinoma (RCC). Aim 1 will use urine collected previously in biorepository. Aim …
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New study tests speedy radiation after spine surgery to beat cancer spread
Disease control Not yet recruitingCurrent guidelines suggest postoperative spine Stereotactic Body Radiation Therapy (SBRT) should be delivered within 2-4 weeks after surgery. This approach is rife with logistical complications that create delays and barriers for patients accessing care. An alternative approach d…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC